Nierenarterienstenose: Neue Erkenntnisse und Entwicklungen

Was ist neu?

• Diagnostik der Niereninsuffizienz: Die geschätzte glomeruläre Filtrationsrate (eGFR) ist zu ungenau für eine zuverlässige Verlaufskontrolle der Nierenfunktion vor und nach Revaskularisation einer NAST im Vergleich zur (125)I-Iothalamat-GFR (iGFR).

• Duplexsonographische Kriterien zur Bestimmung einer Instent-Restenose: Direkte duplexsonographische Grenzwerte einer hämodynamisch relevanten NAST sind höher als für De-Novo-Stenosen in Nativgefäßen.

• Nierenarterien-Stenting: Bei NAST > 60 % zeigt die Stent-Revaskularisierung im Vergleich zur alleinigen medikamentösen Therapie keine zusätzlichen Vorteile.

• Stentangioplastie von NAST bei terminaler Niereninsuffizienz: Bei 8 Patienten normalisierte sich der zuvor unter Medikation therapieresistente Blutdruck nach der Stentangioplastie von NAST.

Schlüsselwörter

Nierenarterienstenose - arterielle Hypertonie - Niereninsuffizienz - Stent - Überleben

Key Words

renal artery stenosis - arterial hypertension - renal insufficiency - stent - survival

• Literaturverzeichnis

• 1 Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J 2011; 32: 2851-2906
• 2 Van Jaarsveld BC, Krijnen P, Pieterman H et al. for the Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis. N Engl J Med 2000; 342: 1007-1014
• 3 Zeller T, Müller C, Frank U et al. Survival after stent-angioplastyofsevereatheroscleroticostial renal arterystenoses. J EndovascTher 2003; 10: 539-545
• 4 Chrysant GS, Bates MC, Sullivan TM et al. HERCULES Investigators. Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial. J ClinHypertens 2014; 16: 497-503
• 5 Plouin PF, Chatellier G, Darne B et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trail. The EMMA-study group. Hypertension 1998; 31: 823-829
• 6 Webster J, Marshall F, Abdalla M et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998; 12: 329-335
• 7 Bax L, Woittiez A-JJ, Kouwenberg HJ et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function A randomized trial. Ann Intern Med 2009; 150: 840-848
• 8 The ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361: 1953-1962
• 9 Cooper CJ, Murphy TP, Cutlip DE et al. for the CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014; 370: 13-22
• 10 Messerli FH, Bangalore S, Makani H et al. Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering Syndrome. Eur Heart J 2011; 32: 2231-2237
• 11 Crimmins GM, Madder RD, Marinescu V et al. Validity of estimated glomerular filtration rates for assessment of renal function after renal artery stenting in patients with atherosclerotic renal artery stenosis. JACC Cardiovasc Interv 2014; 7: 543-549
• 12 Del Conde I, Galin ID, Trost B et al. Renal artery duplex ultrasound criteria for the detection of significant in-stent restenosis. Catheter Cardiovasc Intervent 2014; 83: 612-618
• 13 Bhatt DL, Kandzari DE, O’Neill WW et al. for the SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401
• 14 Riaz IB, Husnain M, Riaz H et al. Meta-analysis of revascularization versus medical therapy for atherosclerotic renal artery stenosis. Am J Cardiol 2014; 114: 1116-1123
• 15 Parikh SA, Shishehbor MH, Gray BH et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv 2014; 84: 1163-1171
• 16 Herrmann SM, Saad A, Textor SC. Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). Nephrol Dial Transplant 2014; DOI: 10.1093/ndt/gfu067.
• 17 Hikita H, Kojima K, Kimura S et al. Impact of renal artery stent implantation on hypertension in patients with hemodialysis. Int J Angiol 2014; 23: 107-110